Is still's disease an autoinflammatory syndrome?

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Rossi Semerano, Linda ^a   Koné Paut, Isabelle ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CANAKINUMAB; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; TOCILIZUMAB;

ARTICLE; AUTOINFLAMMATORY DISEASE; CYTOKINE RELEASE; DRUG EFFICACY; FEVER; HEPATOMEGALY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LYMPHADENOPATHY; PATHOGENESIS; PERICARDITIS; PHAGOCYTE; PLEURISY; PRIORITY JOURNAL; RASH; SPLENOMEGALY;

EID: 84867351535     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/480373     Document Type: Article

References (33)

1. Petty R. E., Southwood T. R., Manners P., Baum J., Glass D. N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A. M., Suarez-Almazor M. E., Woo P., International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001. Journal of Rheumatology 2004 31 2 390 392 2-s2.0-10744230484 (Pubitemid 38160763)
2. Quartier P., Taupin P., Bourdeaut F., Lemelle I., Pillet P., Bost M., Sibilia J., Koné-Paut I., Gandon-Laloum S., LeBideau M., Bader-Meunier B., Mouy R., Debré M., Landais P., Prieur A. M., Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis & Rheumatism 2003 48 4 1093 1101 2-s2.0-0037388345 10.1002/art.10885 (Pubitemid 36418252)
3. Behrens E. M., Beukelman T., Gallo L., Spangler J., Rosenkranz M., Arkachaisri T., Ayala R., Groh B., Finkel T. H., Cron R. Q., Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). Journal of Rheumatology 2008 35 2 343 348 2-s2.0-39549087921 (Pubitemid 351281158)
4. Gurion R., Lehman T. J. A., Moorthy L. N., Systemic arthritis in children: a review of clinical presentation and treatment. International Journal of Inflammation 2012 2012 16 10.1155/2012/271569 271569
5. Masters S. L., Simon A., Aksentijevich I., Kastner D. L., Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annual Review of Immunology 2009 27 621 668 2-s2.0-67650736238 10.1146/annurev.immunol.25.022106.141627
6. Luthi F., Zufferey P., Hofer M. F., So A. K., Adolescent-onset Still's disease: characteristics and outcome in comparison with adult-onset Still's disease. Clinical and Experimental Rheumatology 2002 20 3 427 430 2-s2.0-0036558994 (Pubitemid 35012583)
7. Behrens E. M., Beukelman T., Paessler M., Cron R. Q., Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. Journal of Rheumatology 2007 34 5 1133 1138 2-s2.0-34248666067 (Pubitemid 46774861)
8. Bleesing J., Prada A., Siegel D. M., Villanueva J., Olson J., Ilowite N. T., Brunner H. I., Griffin T., Graham T. B., Sherry D. D., Passo M. H., Ramanan A. V., Filipovich A., Grom A. A., The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α -chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis & Rheumatism 2007 56 3 965 971 2-s2.0-33947158702 10.1002/art.22416 (Pubitemid 46399444)
9. Vastert S. J., van Wijk R., D'Urbano L. E., de Vooght K. M., de Jager W., Ravelli A., Magni-Manzoni S., Insalaco A., Cortis E., van Solinge W. W., Prakken B. J., Wulffraat N. M., de Benedetti F., Kuis W., Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 2009 49 3 441 449 2-s2.0-77950531755 10.1093/rheumatology/kep418
10. Davì S., Consolaro A., Guseinova D., Pistorio A., Ruperto N., Martini A., Cron R. Q., Ravelli A., An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Journal of Rheumatology 2011 38 4 764 768 2-s2.0-79953309677 10.3899/jrheum.100996
11. Lin Y. T., Wang C. T., Gershwin M. E., Chiang B. L., The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmunity Reviews 2011 10 8 482 489 2-s2.0-79957643739 10.1016/j.autrev.2011. 02.001
12. Pascual V., Allantaz F., Arce E., Punaro M., Banchereau J., Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. Journal of Experimental Medicine 2005 201 9 1479 1486 2-s2.0-18644385243 10.1084/jem.20050473 (Pubitemid 40664091)
13. Prakken B., Albani S., Martini A., Juvenile idiopathic arthritis. The Lancet 2011 377 9783 2138 2149 2-s2.0-79959370461 10.1016/S0140-6736(11)60244-4
14. Mellins E. D., MacAubas C., Grom A. A., Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nature Reviews Rheumatology 2011 7 7 416 426 2-s2.0-79959963298 10.1038/nrrheum.2011.68
15. De Jager W., Hoppenreijs E. P. A. H., Wulffraat N. M., Wedderburn L. R., Kuis W., Prakken B. J., Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Annals of the Rheumatic Diseases 2007 66 5 589 598 2-s2.0-34248147607 10.1136/ard.2006.061853 (Pubitemid 46707126)
16. De Benedetti F., Massa M., Robbioni P., Ravelli A., Burgio G. R., Martini A., Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis & Rheumatism 1991 34 9 1158 1163 2-s2.0-0026014522 10.1002/art.1780340912
17. Foell D., Roth J., Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis & Rheumatism 2004 50 12 3762 3771 2-s2.0-10444270993 10.1002/art.20631 (Pubitemid 39643922)
18. Quartier P., Allantaz F., Cimaz R., Pillet P., Messiaen C., Bardin C., Bossuyt X., Boutten A., Bienvenu J., Duquesne A., Richer O., Chaussabel D., Mogenet A., Banchereau J., Treluyer J. M., Landais P., Pascual V., A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Annals of the Rheumatic Diseases 2011 70 5 747 754 2-s2.0-79953323633 10.1136/ard.2010.134254
19. Lequerré T., Quartier P., Rosellini D., Alaoui F., De Bandt M., Mejjad O., Kone-Paut I., Michel M., Demis E., Khellaf M., Limai N., Job-Deslandre C., Fautrel B., Le Loët X., Sibilia J., Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Annals of the Rheumatic Diseases 2008 67 3 302 308 2-s2.0-39549109506 10.1136/ard.2007.076034 (Pubitemid 351281262)
20. Gattorno M., Piccini A., Lasigliè D., Tassi S., Brisca G., Carta S., Delfino L., Ferlito F., Pelagatti M. A., Caroli F., Buoncompagni A., Viola S., Loy A., Sironi M., Vecchi A., Ravelli A., Martini A., Rubartelli A., The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis & Rheumatism 2008 58 5 1505 1515 2-s2.0-43949116263 10.1002/art.23437 (Pubitemid 351705940)
21. Nigrovic P. A., Mannion M., Prince F. H. M., Zeft A., Rabinovich C. E., van Rossum M. A. J., Cortis E., Pardeo M., Miettunen P. M., Janow G., Birmingham J., Eggebeen A., Janssen E., Shulman A. I., Son M. B., Hong S., Jones K., Ilowite N. T., Cron R. Q., Higgins G. C., Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis & Rheumatism 2011 63 2 545 555 2-s2.0-79551654446 10.1002/art.30128
22. Goldbach-Mansky R., Dailey N. J., Canna S. W., Gelabert A., Jones J., Rubin B. I., Kim H. J., Brewer C., Zalewski C., Wiggs E., Hill S., Turner M. L., Karp B. I., Aksentijevich I., Pucino F., Penzak S. R., Haverkamp M. H., Stein L., Adams B. S., Moore T. L., Fuhlbrigge R. C., Shaham B., Jarvis J. N., O'Neil K., Vehe R. K., Beitz L. O., Gardner G., Hannan W. P., Warren R. W., Horn W., Cole J. L., Paul S. M., Hawkins P. N., Tuyet H. P., Snyder C., Wesley R. A., Hoffmann S. C., Holland S. M., Butman J. A., Kastner D. L., Neonatal-onset multisystem inflammatory disease responsive to interleukin-1 β inhibition. The New England Journal of Medicine 2006 355 6 581 592 2-s2.0-33746876396 10.1056/NEJMoa055137 (Pubitemid 44200651)
23. Ruperto N., Quartier P., Wulffraat N., A phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis & Rheumatism 2012 64 2 557 567
24. Lovell D. J., Giannini E. H., Kimura Y., Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis (SJIA). Arthritis & Rheumatism 2009 60, supplement S768
25. De Benedetti F., Martini A., Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? The Journal of Rheumatology 1998 25 2 203 207 2-s2.0-0031993121
26. Fonseca J. E., Santos M. J., Canhão H., Choy E., Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmunity Reviews 2009 8 7 538 542 2-s2.0-67349104400 10.1016/j.autrev.2009.01.012
27. Fishman D., Faulds G., Jeffey R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 1998 102 7 1369 1376 2-s2.0-0032189103 (Pubitemid 28467565)
28. Ogilvie E. M., Fife M. S., Thompson S. D., Twine N., Tsoras M., Moroldo M., Fisher S. A., Lewis C. M., Prieur A. M., Glass D. N., Woo P., The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis & Rheumatism 2003 48 11 3202 3206 2-s2.0-0242579549 10.1002/art.11300 (Pubitemid 37409332)
29. Yokota S., Imagawa T., Mori M., Miyamae T., Aihara Y., Takei S., Iwata N., Umebayashi H., Murata T., Miyoshi M., Tomiita M., Nishimoto N., Kishimoto T., Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. The Lancet 2008 371 9617 998 1006 2-s2.0-40749152243 10.1016/S0140-6736(08)60454-7 (Pubitemid 351389534)
30. De Benedetti F., Brunner H. I., Ruperto N., Efficacy and safety of tocilizumab in patients with systemic juvenile idiopathic arthritis (sJIA): 12-week data from the phase 3 TENDER trial. Annals of the Rheumatic Diseases 2010 69, supplement 146
31. Maeno N., Takei S., Nomura Y., Imanaka H., Hokonohara M., Miyata K., Yamamura M., Kawashima M., Makino H., Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease. Arthritis & Rheumatism 2002 46 9 2539 2542 2-s2.0-0036746084 10.1002/art.10389
32. Kawashima M., Yamamura M., Taniai M., Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis & Rheumatism 2001 44 550 560 (Pubitemid 32234613)
33. De Jager W., Vastert S. J., Beekman J. M., Wulffraat N. M., Kuis W., Coffer P. J., Prakken B. J., Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis & Rheumatism 2009 60 9 2782 2793 2-s2.0-69449093422 10.1002/art.24750